Born: 1958, United States
Died: NA
Country most active: United States
Also known as: Sue Desmond
The following is republished from The White House. This piece falls under under public domain, as copyright does not apply to “any work of the U.S. Government” where “a work prepared by an officer or employee of the U.S. Government as part of that person’s official duties” (See, 17 U.S.C. §§ 101, 105).
Sue Desmond-Hellmann, MD, MPH, is a physician-scientist who led the development of the first gene-targeted drug for treating breast cancer.
Medical, scientific, and philanthropic career spanning 40 years: from academic medicine and clinical practice studying cancer and HIV/AIDS, to running research and product development at some of America’s top biotechnology companies, to leading higher education at one of California’s marquis graduate institutions, to running the world’s largest private foundation.
Former Chancellor of the University of California, San Francisco (2009-2014), and the first woman to hold the position.
At the leading biotech firm Genentech (1995-2009), led development of Herceptin® and served as Chief Medical Officer.
Member of U.S. National Academy of Medicine.
Co-chaired influential National Academies report that defined and charted the course of precision medicine.